meta|evidence oncology
  • Living systematic review and meta-analysis
 
  • breast cancer - HR positive
  • es-BC - HR positive - (neo)adjuvant (NA) 2
  • es-BC - HR-positive - 1st line (L1) 1
  • la/mBC - HR positive 3
  • la/mBC - HR positive - (neo)adjuvant (NA) 3
  • la/mBC - HR positive - NA - PIK3CA mutant
  • la/mBC - HR-positive - 1st line (L1) 13
  • la/mBC - HR positive - L1 - PIK3CA mutant 1
  • la/mBC - HR-positive - 2nd line (L2) 20
  • la/mBC - HR positive - L2 - all population 2
  • la/mBC - HR positive - L2 - PIK3CA mutant 1